Ownership history in Eversept Partners, LP Β· 30 quarters on record
This page tracks every 13F SEC filing in which Eversept Partners, LP reported a position in AMARIN CORP PLC (AMRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Eversept Partners, LP outperformed the S&P 500 by +29.9% annually on this AMRN position. Timing score: 58% (15/26 decisions correct). Average cost basis: $96.78. Maximum drawdown during holding period: β97.9%.
π₯ Exceptional β beat the S&P 500 by 29.9% per year on this position.
28 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
15 of 26 add/trim decisions correct
Best entry: $9.00 (2025 Q1) Β· Worst: $415.20 (2019 Q1)
πͺ Held through 2 major drawdowns (>20%).
13 adds Β· 15 trims. Bought during 5 of 17 down-price quarters. π Predominantly trimming β distribution phase.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.12% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size